Improving HIV prevention methods for young people in Zambia

Optimizing implementation of long-acting, injectable Cabotegravir for HIV prevention among adolescents and young adults in Zambia

NIH-funded research Johns Hopkins University · NIH-10904745

This study is looking for ways to make it easier for young people in Zambia to get a long-lasting HIV prevention shot, so they can stay healthy and safe, and it invites them to share their thoughts on how well it works.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-10904745 on NIH RePORTER

What this research studies

This research focuses on enhancing the implementation of long-acting injectable Cabotegravir as a preventive measure against HIV among adolescents and young adults in Zambia. The project aims to develop effective strategies for delivering this intervention in low-resource settings, ensuring that it meets the needs of high-risk populations. By utilizing evidence-based approaches and engaging with stakeholders, the research seeks to optimize the impact of HIV prevention efforts. Participants may be involved in various aspects, including data collection and feedback on the intervention's effectiveness.

Who could benefit from this research

Good fit: Ideal candidates for this research are adolescents and young adults at high risk for HIV in Zambia.

Not a fit: Patients who are not at risk for HIV or those who do not reside in Zambia may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of HIV among young people in Zambia.

How similar studies have performed: Previous research has shown promising results in implementing long-acting HIV prevention methods in similar populations.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.